Managing IBD in the COVID-19 era.

Authors:
Scalzo N; Ungaro RC.

Journal:
Therap Adv Gastroenterol

Publication Year: 2023

DOI:
10.1177/17562848231176450

PMCID:
PMC10273097

PMID:
37337593

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Therap Adv Gastroenterol

Abbreviation: Therap Adv Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and…
Li M; Chen S; Li S and 13 more (2024) - Transparency Score: 3/6
Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in in…
Nigam GB; Chatten K; Sharara A and 6 more (2024) - Transparency Score: 4/6
Chemotherapy combined with targeted therapy and immunotherapy is an option in advanced biliary trac…
Ge P; Wu Y. (2024) - Transparency Score: 3/6
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with u…
Calafat M; Torres P; Tosca-Cuquerella J and 56 more (2024) - Transparency Score: 3/6
Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should <i>K…
Béchade D; Palmieri LJ; Bonhomme B and 7 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"R. Ungaro has served as an advisory board member or consultant for AbbVie, Bristol Myers Squibb, Janssen, Pfizer and Takeda, and has received research support from AbbVie, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly and Pfizer."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: R. Ungaro is funded by an NIH K23 Career Development Award [K23 KD111995-01A1]."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025